MERCK & CO., INC. (MRK)
Clinical trial NCT03162536 updates: 1. completion date: 2026-09-18 → 2027-09-17 2. primary completion date: 2026-09-18 → 2027-09-17
Clinical trial NCT03162536 updates: 1. completion date: 2026-09-18 → 2027-09-17 2. primary completion date: 2026-09-18 → 2027-09-17
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical